Adapting judicial supervision to the risk level of drug offenders: Discharge and 6-month outcomes from a prospective matching study

References 

1. Alterman AI, McDermott PA, Cook TG, Metzger D, Rutherford MJ, Cacciola JS, et al. New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent. Psychol. Addict. Behav. 1998;12:233–246
   • CrossRef
2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000;
3. Andrews DA, Bonta J. The Psychology of Criminal Conduct. 2nd ed.. Cincinnati, OH: Anderson; 1998;
4. Belenko S. Research on drug courts: a critical review. Natl. Drug Court Inst. Rev. 1998;1:1–42
5. Belenko S. Research on drug courts: a critical review: 1999 update. Natl. Drug Court Inst. Rev. 1999;2:1–58
6. Belenko S. Research on Drug Courts: A Critical Review: 2001 Update. New York: National Center on Addiction and Substance Abuse at Columbia Univ.; 2001;
7. Cacciola JS, Koppenhaver JM, McKay JR, Alterman AI. Test-retest reliability of the lifetime items on the addiction severity index. Psychol. Assess. 1999;11:86–93
   • CrossRef
8. Collins LM, Murphy SA, Bierman KA. A conseptual framework for adaptive preventive interventions. Prevention Science. 2004;5:185–196
9. DeMatteo DS, Marlowe DB, Festinger DS. Secondary prevention services for clients who are low risk in drug court: a conceptual model. Crime Delinquency. 2006;52:114–134
10. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York: Oxford University Press; 1994;
11. Festinger DS, DeMatteo DS, Marlowe DB, Lee PA. Expungement of arrest records in drug court: Do clients know what they’re missing?. Drug Court Rev. 2005;5:1–21
12. Festinger DS, Marlowe DB, Lee PA, Kirby KC, Bovasso G, McLellan AT. Status hearings in drug court: when more is less and less is more. Drug Alcohol Depend. 2002;68:151–157
    • Abstract
    • Full Text
    • Full-Text PDF (208 KB)
    • CrossRef
13. Finigan MW. Assessing cost off-sets in a drug court setting. Natl. Drug Court Inst. Rev. 1999;2:59–91
14. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis II Personality Disorders. Arlington, VA: American Psychiatric Press; 1997;
15. Gendreau P, Little T, Goggin C. A meta-analysis of the predictors of adult offender recidivism: What works!. Criminology. 1996;34:575–596
16. Goldkamp J. Do drug courts work? Getting inside the drug court black box. J. Drug Issues. 2001;31:27–72
17. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute; 1996;
18. Marlowe DB, DeMatteo DS, Festinger DS. A sober assessment of drug courts. Fed. Sent. Rep. 2003;16:153–157
19. Marlowe DB, Festinger DS, Dugosh KL, Lee PA. Are judicial status hearings a “key component” of drug court? Six and twelve months outcomes. Drug Alcohol Depend. 2005;79:145–155
    • Abstract
    • Full Text
    • Full-Text PDF (129 KB)
    • CrossRef
20. Marlowe DB, Festinger DS, Lee PA. The role of judicial status hearings in drug court. Offender Subst. Abuse Rep. 2003;3:33–46
21. Marlowe DB, Festinger DS, Lee PA. The judge is a key component of drug court. Drug Court Rev. 2004;4:1–34
22. Marlowe DB, Festinger DS, Lee PA, Dugosh KL, Benasutti KM. Matching judicial supervision to clients’ risk status in drug court. Crime Delinquency. 2006;52:52–76
23. Marlowe DB, Festinger DS, Lee PA, Schepise MM, Hazzard JER, Merrill JC, et al. Are judicial status hearings a key component of drug court? During-treatment data from a randomized trial. Crim. Justice Behav. 2003;30:141–162
24. Marlowe DB, Kirby KC. Effective use of sanctions in drug courts: Lessons from behavioral research. Natl. Drug Court Inst. Rev. 1999;2:1–31
25. Marlowe DB, Patapis NS, DeMatteo DS. Amenability to treatment of drug offenders. Fed. Probation. 2003;67:40–46
26. McDermott PA, Alterman AI, Brown L, Zaballero A, Snider EC, McKay JR. Construct refinement and confirmation for the addiction severity index. Psychol. Assess. 1996;8:182–189
    • CrossRef
27. McLellan AT, Cacciola J, Kushner H, Peters R, Smith I, Pettinati H. The fifth edition of the addiction severity index: cautions, additions and normative data. J. Subst. Abuse Treat. 1992;9:461–480
28. McLellan AT, Luborsky L, Cacciola JC, Griffith J, Evans F, Barr HL, et al. New data from the addiction severity index: reliability and validity in three centers. J. Nerv. Ment. Dis. 1985;173:412–423
    • MEDLINE
    • CrossRef
29. McLellan AT, Luborsky L, O’Brien CP, Woody GE. An improved diagnostic instrument for substance abuse clients: the addiction severity index. J. Nerv. Ment. Dis. 1980;168:26–33
    • MEDLINE
    • CrossRef
30. Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat. Med. 2005;24:1455–1481
    • MEDLINE
    • CrossRef
31. National Association of Drug Court Professionals . Defining Drug Courts: The Key Components. Washington, DC: Office of Justice Programs, US Dept. of Justice; 1997;
32. Peters RH, Haas AL, Murrin MR. Predictors of retention and arrest in drug court. Natl. Drug Court Inst. Rev. 1999;2:33–60
33. SAS Institute . SAS/STAT Software: Changes and Enhancements Through Release 8.02. Cary, NC: SAS Institute, Inc.; 2001;
34. Satel SL. Drug Treatment: The Case for Coercion. Washington, DC: American Enterprise Institute; 1999;
35. Schottenfeld RS. Involuntary treatment of substance abuse disorders—impediments to success. Psychiatry. 1989;52:164–176
    • MEDLINE
36. Taxman, F.S., Marlowe, D.B. (Eds.), 2006. Risk, needs, responsivity: in action or inaction? [Introduction to special issue]. Crime Delinquency 52, 3–6.
37. US Government Accountability Office . Adult Drug Courts: Evidence Indicates Recidivism Reductions and Mixed Results for Other Outcomes [No. GAO-05-219]. Washington, DC: US Government Accountability Office; 2005;